Specific paradigm for wound bed preparation in chronic wounds

International Congress and Symposium Series - Royal Society of Medicine

Volumn , Issue 250, 2001, Pages 33-39

  Brem, Harold ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949945615     PISSN: 01422367     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (24)

1. Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 319-26.
2. Brem H, Folkman J. Angiogenesis and basic fibroblast growth factor during wound healing. In: Brighton CT, Friedlander GE, Lane J.M, eds. Bone formation and repair. Rosemont, IL: American Academy of Orthopaedic Surgeons, 1994: 213-22.
3. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In: Harris MI, Cowie CC, Reiber G et al, eds. Diabetes in America. Washington, DC; U.S. Government Printing Office, 1995: 409-28.
4. Eckman MH, Greenfield S, Mackey WC et al. Foot infections in diabetic patients: decision and cost-effectiveness analyses. JAMA 1995; 273: 712-20.
5. Hirshberg J, Rees RS, Marchant B, Dean S. Osteomyelitis related to pressure ulcers: the cost of neglect. Adv Skin Wound Care 2000; 13: 25-29.
6. Cuhna BA. Antibiotic selection for diabetic foot infections: a review. J Foot Ankle Surg 2000; 39: 253-7.
7. Pittet D, Wyssa B, Herter-Clavel C et al. Outcome of diabetic foot infections treated conservatively. Arch Intern Med 1999; 159: 851-6.
8. Nehler MR, Whitehill TA, Bowers SP et al. Intermediate-term outcome of primary digit amputations in patients with diabetes mellitus who have forefoot sepsis requiring hospitalization and presumed adequate circulatory status. J Vase Surg 1999; 30: 509-18.
9. Latinkic BV, Mo FE, GreenspanJA et al. Promoter function of the angiogenic inducer Cyr6I gene in transgenic mice: tissue specificity, inducibility during wound healing, nad role of the serum response element. Endocrinology 2001; 142: 2549-57.
10. Guerin C, Laterra J, Masnyk T et al. Selective endothelial growth inhibition by tetracyclines that inhibit collagenase. Biocbem Biopbys Res Commun 1992 Oct 30; 188: 740-5.
11. Tamargo RJ, Bok RA, Brem H. Angiogenesis inhibition by minocycline. Cancer Res 1991; 51: 672-5.
12. Fidler IJ. Angiogenesis and cancer metastasis. Cancer J Sci Am 2000; 6(suppl 2): SI34-41.
13. Partridge CR, Hawker JR Jr, Forough R. Overexpression of a secretory form of FGF-1 promotes MLMP-l-mediated endothelial cell migration. J Cell Biochem 2000; 78: 487-99.
14. Reed All, Corsa AC, Kudravi SA et al. A deficit in collagenase activity contributes to impaired migration of 3ged microvascular endothelial cells. J Cell Biochem; 77: 116-26.
15. Steed DL. Foundations of good care. Am Surg 1998; 176(suppl 2A): 20S-25S.
16. Knight EV, Oldham JW, Mohler A1A et al. A review of nonclinical toxicology studies of becaplennin (rhPDGF-BB). Am Surg 1998; 176(suppl 2A): 55S-40S.
17. LeGrand EK. Preclinical promise of becaplermin (rhPDGF-BB) in wound healing. Am Surg 1998; 176(suppl 2A): 26S-38S.
18. Falanga V, Margolis D, Alvaraez O et al. Rapid healing of venous ulcers and lack of clinical rejection with allogeneic cultured human skin equivalent. Arch Dermatol 1998; 134: 293-300.
19. Parenteau N. Skin: the first tissue-engineered products. Sci Am 1999; 280: 83-4.
20. Falanga V, Sabolinski M. A bilayered skin construct (Apligraf) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 1999; 7: 201-7.
21. Falanga VJ. Tissue engineering in wound repair. Adv Skin Wound Care 2000; 13(suppl 2): 15-9.
22. Brem H, BalleduxJ, Bloom T et al. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing. Arch Surg 2000; 6: 627-34.
23. Veves A, Falanga V, Armstrong, Sabolinski AIL. Graftskin, a human skin equivalent, is effective in the management of neuropathic diabetic foot ulcers: a prospective randomized clinical trial. Diabetes Care 2001; 24: 290-5.
24. th Annual European Tissue Repair Society Meeting, Brussels, Belgium; Wound Rep Regen 2001; 9: 136.